PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver Disease. (2022)
Attributed to:
Liverpool COVID-19 Drug Interactions (www.covid19-druginteractions.org)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2022.814134
PubMed Identifier: 35153785
Publication URI: http://europepmc.org/abstract/MED/35153785
Type: Journal Article/Review
Volume: 13
Parent Publication: Frontiers in pharmacology
ISSN: 1663-9812